These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11307150)

  • 1. Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma.
    Bartel F; Meye A; Würl P; Kappler M; Bache M; Lautenschläger C; Grünbaum U; Schmidt H; Taubert H
    Int J Cancer; 2001 May; 95(3):168-75. PubMed ID: 11307150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis.
    Bartel F; Schulz J; Böhnke A; Blümke K; Kappler M; Bache M; Schmidt H; Würl P; Taubert H; Hauptmann S
    Int J Cancer; 2005 Nov; 117(3):469-75. PubMed ID: 15906355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
    Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
    Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
    J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stages.
    Taubert H; Schuster K; Brinck U; Bartel F; Kappler M; Lautenschläger C; Bache M; Trump C; Schmidt H; Holzhausen HJ; Würl P; Schlott T
    Mod Pathol; 2003 Nov; 16(11):1109-16. PubMed ID: 14614050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HDMX amplification and high levels of HDMX-S splice variant are correlated with a poor prognosis in soft tissue sarcomas].
    Bartel F; Schulz J; Blümke K; Kappler M; Bache M; Schmidt H; Taubert H
    Verh Dtsch Ges Pathol; 2004; 88():199-206. PubMed ID: 16892553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells.
    Kraus A; Neff F; Behn M; Schuermann M; Muenkel K; Schlegel J
    Int J Cancer; 1999 Mar; 80(6):930-4. PubMed ID: 10074928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mdm2 mRNA level is a prognostic factor in soft tissue sarcoma.
    Taubert H; Koehler T; Meye A; Bartel F; Lautenschläger C; Borchert S; Bache M; Schmidt H; Würl P
    Mol Med; 2000 Jan; 6(1):50-9. PubMed ID: 10803408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines.
    Weng MW; Lai JC; Hsu CP; Yu KY; Chen CY; Lin TS; Lai WW; Lee H; Ko JL
    Environ Mol Mutagen; 2005 Jul; 46(1):1-11. PubMed ID: 15714438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms.
    Matsumoto R; Tada M; Nozaki M; Zhang CL; Sawamura Y; Abe H
    Cancer Res; 1998 Feb; 58(4):609-13. PubMed ID: 9485008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.
    Evdokiou A; Atkins GJ; Bouralexis S; Hay S; Raggatt LJ; Cowled PA; Graves SE; Clayer M; Findlay DM
    Int J Oncol; 2001 Sep; 19(3):625-32. PubMed ID: 11494046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2.
    Evans SC; Viswanathan M; Grier JD; Narayana M; El-Naggar AK; Lozano G
    Oncogene; 2001 Jul; 20(30):4041-9. PubMed ID: 11494132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors.
    Nakayama T; Toguchida J; Wadayama B; Kanoe H; Kotoura Y; Sasaki MS
    Int J Cancer; 1995 Oct; 64(5):342-6. PubMed ID: 7591308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis.
    Steinman HA; Burstein E; Lengner C; Gosselin J; Pihan G; Duckett CS; Jones SN
    J Biol Chem; 2004 Feb; 279(6):4877-86. PubMed ID: 14612455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas.
    Forus A; Flørenes VA; Maelandsmo GM; Fodstad O; Myklebost O
    Cancer Genet Cytogenet; 1994 Dec; 78(2):165-71. PubMed ID: 7828148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific.
    Bartel F; Pinkert D; Fiedler W; Kappler M; Würl P; Schmidt H; Taubert H
    Int J Oncol; 2004 Jan; 24(1):143-51. PubMed ID: 14654951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas.
    Nasir L; Rutteman GR; Reid SW; Schulze C; Argyle DJ
    Cancer Lett; 2001 Dec; 174(1):83-9. PubMed ID: 11675155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of the human oncoprotein MDM2 in benign and malignant tumors of the salivary gland.
    Schlott T; Nagel H; Laskawi R; Eiffert H; Droese M
    Pathobiology; 2001; 69(2):67-76. PubMed ID: 11752900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor promotion by Mdm2 splice variants unable to bind p53.
    Fridman JS; Hernando E; Hemann MT; de Stanchina E; Cordon-Cardo C; Lowe SW
    Cancer Res; 2003 Sep; 63(18):5703-6. PubMed ID: 14522887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.